Healthcare Industry News: Solos Endoscopy
News Release - May 9, 2006
Solos Endoscopy, Inc. Appoints Medical Technology Executive as Acting Vice PresidentBOSTON, MA--(Healthcare Sales & Marketing Network)--May 9, 2006 -- Solos Endoscopy, Inc. (Other OTC:SLSE.PK ) is pleased to announce that the Company has appointed medical technology executive Dom L. Gatto as acting Executive Vice President. Mr. Gatto's responsibilities will include handling all aspects of the sales and marketing, operations, and new product introductions. Additionally, he will oversee all business development activities of the company. Mr. Gatto previously lead the clinician team in their product development projects for Solos.
Mr. Gatto received his B.A. from Quinnipiac University and has attended the Executive Management Program at UCLA's John Anderson School of Business. Mr. Gatto started out his career as a product manager for one of the world's largest producers of medical textile products, CoNco Medical Corporation. Mr. Gatto later worked with Merocel Corporation which became Xomed Inc., where he formed a new business unit to design, develop, manufacture, and market minimally invasive ENT (Ear, Nose, and Throat) products. Mr. Gatto developed the operation to the point where it was financially successful within its first year of sales, reaching $2 million in revenues. He has also successfully developed and launched a product line of innovative minimally invasive handheld sinus instruments and a self-irrigating powered tissue removal system, the first of its kind, for the ENT market. He then went on and founded MedTREK Corporation in 1997. MedTREK developed and distributed patented sinus endoscopy instrumentation. In 2000, after establishing the product line and worldwide distribution rights for MedTREK Corporation's products, Mr. Gatto joined the start up breast cancer detection company Acueity, Inc. as Senior Vice President of Operations.
"Solos Endoscopy is privileged to be working alongside a professional of Dom Gatto's knowledge and expertise. Mr. Gatto will be able to provide invaluable feedback to us concerning the development of both our business and our endoscopic products. We believe that his past experience and success in the medical device market will translate into future success for our company and its shareholders," stated Robert Segersten, President of Solos Endoscopy, Inc.
About Solos Endoscopy, Inc.
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Source: Solos Endoscopy
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.